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Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CaliforniaABSTRACT Cholesterol binding to G protein-coupled receptors (GPCRs) and modulation of their activities in membranes is a
fundamental issue for understanding their function. Despite the identification of cholesterol binding sites in high-resolution x-ray
structures of the b2 adrenergic receptor (b2AR) and other GPCRs, the binding affinity of cholesterol for this receptor and ex-
change rates between the free and bound cholesterol remain unknown. In this study we report the existence of two classes
of cholesterol binding sites in b2AR. By analyzing the b2AR unfolding temperature in lipidic cubic phase (LCP) as a function
of cholesterol concentration we observed high-affinity cooperative binding of cholesterol with sub-nM affinity constant. In
contrast, saturation transfer difference (STD) NMR experiments revealed the existence of a second class of cholesterol binding
sites, in fast exchange on the STD NMR timescale. Titration of the STD signal as a function of cholesterol concentration provided
a lower limit of 100mM for their dissociation constant. However, these binding sites are specific for both cholesterol and b2AR, as
shown with control experiments using ergosterol and a control membrane protein (KpOmpA). We postulate that this specificity is
mediated by the high-affinity bound cholesterol molecules and propose the formation of transient cholesterol clusters around
the high-affinity binding sites.INTRODUCTIONEffects of cholesterol on the stability and function of G pro-
tein-coupled receptors (GPCRs) have been known for at
least two decades (1–3). However, there is often no clear
consensus as to whether the effects of cholesterol on indi-
vidual protein species arise from a specific GPCR-choles-
terol interaction, from the effect of cholesterol on the bulk
properties of the lipid bilayer, or from a combination of
both (4). The publication of crystal structures of the b2
adrenergic receptor (b2AR) in 2007–2008 allowed the first
visualization of direct interactions between this receptor
and cholesterol (5,6). Since that time, cholesterol binding
sites have been identified in the crystal structures of six
different GPCRs: the b1 adrenergic receptor (7), the adeno-
sine A2a receptor (8), the m-opioid receptor (9), the serotonin
2B receptor (10), the metabotropic glutamate receptor 1
(11), and the purinergic receptor P2Y12 (12). Crystallog-
raphy, however, provides only static pictures, whereas it
is important to determine affinities and exchange rates to
fully understand how cholesterol interacts with GPCRs in
a dynamic environment.
Lipidic cubic phase (LCP) represents a convenient mem-
brane mimetic matrix for studying effects of lipids on mem-
brane protein structure, function, and stability (13). In
particular, LCP can be used to reconstitute active membrane
proteins within a local highly curved bilayer-like structureSubmitted June 27, 2014, and accepted for publication October 9, 2014.
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0006-3495/14/11/2305/8 $2.00containing certain lipids or sterols that are necessary for
protein function. LCP has the consistency of a transparent
gel, which is amenable for variety of spectroscopic ap-
proaches (6,14). Moreover, LCP supports the crystallization
of membrane proteins directly from the lipidic environment
(15); this method has been instrumental for structure deter-
mination of ~ 60 different membrane proteins, including 25
different GPCRs. LCP also presents several interesting
properties from the perspective of NMR spectroscopy. First,
LCP is composed of membrane-like lipid bilayers at high
density (lipid content is ~ 50%), in which different classes
of integral membrane proteins can be reconstituted in a
functional state (see reviews (16,17) and references therein).
Second, the bulk LCP is isotropic, with rapid diffusion of
lipid molecules (18,19). This reorientation of lipid mole-
cules on the NMR timescale leads to averaging of the aniso-
tropic components of the NMR signal that are responsible
for broadening of peaks in anisotropic lipid phases (e.g.,
lamellar or hexagonal phases). Therefore, it is possible to
acquire almost liquid-like spectra of the lipid components
of LCP in terms of line-width and intensity, and the NMR
spectra of LCP samples have even been recorded in a solu-
tion state probe (20), although we observed that high resolu-
tion–magic angle spinning (HR-MAS) improves resolution.
NMR methods that rely on parameters accessible in
isotropic systems, such as polarization transfer rates (21),
relaxation times (22), and line-shapes (23) have also been
applied successfully in LCP.http://dx.doi.org/10.1016/j.bpj.2014.10.011
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FIGURE 1 Sterol structures with numbered carbon positions.
2306 Gater et al.Saturation transfer difference (STD) is a well-established
technique in NMR that has found use predominantly as a
method to screen soluble small-molecule ligands for pro-
teins of pharmaceutical interest (24,25). The basis for the
method is to measure the transfer of magnetization to a
ligand following selective irradiation of the protein. Such
an incoherent Nuclear Overhauser Effect (NOE) process
has an r6 distance dependence and is therefore strongly
correlated with interaction between the protein and the
ligand (structure of the complex and contact probability),
as well as with the exchange rates between bound and free
states. Several variations of the original solution-state 1H
STD method have been published, including heteronuclear
experiments with irradiation of the protein 1H atoms and
measurement of the 13C ligand resonances (26,27), and
group-selective techniques to measure weak interactions
(28). Other advances in the application of STD, including
the use of 1H-19F heteronuclear STD, are described in a
recent review (29). STD NMR has been used extensively
in the context of membrane protein-lipid interactions by
Soubias, Gawrisch, and collaborators to demonstrate that
rhodopsin preferentially interacts with docosahexaenoic
acid (DHA) containing lipids as well as with phosphatidyl
ethanolamine (PE) containing lipids, as reviewed in (30).
In this study, we present to our knowledge, new insights
into cholesterol-b2AR interactions obtained by LCP-Tm
thermostability measurements (14) and STD NMR. LCP-
Tm suggests the existence of high-affinity cholesterol-spe-
cific binding sites, whereas STD experiments reveal the
presence of a second class of low-affinity cholesterol bind-
ing sites. Using ergosterol, a structurally related yeast sterol
(see Fig. 1), and Klebsiella pneumoniae outer membrane
protein A (KpOmpA) (31), we confirm that both the low-
and high-affinity binding sites of cholesterol on b2AR are
specific to the fine molecular details of cholesterol.MATERIALS AND METHODS
Protein expression and purification
b2AR
The same engineered human b2-adrenergic receptor-T4 lysozyme chimeric
construct, b2AR-T4L, as the one previously crystallized, was used in this
study, and was expressed and purified as previously described (see (6)
and Supplementary Material). Final protein solutions contained 50 mg/ml
b2AR with 20 mM HEPES pH 7.5, 150 mM NaCl, 200 mM imidazole,
0.05% w/v n-dodecyl-b-D-maltoside (DDM), 0.01% w/v cholesteryl hemi-
succinate (CHS), and 50 mM carazolol (for NMR and LCP-Tm) or 500 mM
timolol (for LCP-Tm). Protein concentration was determined by integration
of the 280 nm absorption peak on the size exclusion chromatography (SEC)
elution profile. For NMR samples, the last wash (20 column volume) and
elution from Ni column was done using buffers prepared with D2O (Sigma,
99.99% purity).
KpOmpA
The cloning, expression and purification of the Klebsiella pneumoniae outer
membrane protein A (KpOmpA) transmembrane domain were performedBiophysical Journal 107(10) 2305–2312as previously described (see (31) and Supplementary Material). The final
solution thus contained 25 mg/ml KpOmpA in 50 mM HEPES (pH 7.5—
corrected for deuterated solvent (32)), 150 mM NaCl, 0.05% w/v DDM,
0.01% w/v CHS, and 200 mM imidazole in D2O. The final protein concen-
tration was also verified spectrophotometrically.Sample preparation for NMR
Monoolein (MO) was purchased from NU-CHECK Prep, Inc., Elysian,
MN. Cholesterol (including 25,26,27-13C3-cholesterol), 7-dehydrocholes-
terol, ergosterol, stigmasterol, HEPES, imidazole, and CHS were purchased
from Sigma-Aldrich Chemie Sarl, Saint-Quentin Fallavier, France; sodium
chloride from EUROMEDEX, Souffelweyersheim, France; and DDM and
Zwittergent 3-14 (N-tetradecyl-N,N-dimethyl-3-ammonio-1-propanesulfo-
nate) from MERCK KGaA, Darmstadt, Germany. D2O (99.85 atom%)
was obtained from EURISO-TOP SA, Saint-Aubin, France; and chloroform
(used in sample preparation) from VWR, Fontenay sous Bois, France. All
materials were used without further purification. The standard buffer
preparation included 50 mM HEPES at pH 7.5, 150 mM NaCl, 200 mM
imidazole, 0.05% w/v DDM, and 0.01% w/v CHS in D2O.
MO, cholesterol at the specified concentration, and ergosterol (if
required) were dissolved in chloroform and mixed in the desired molar ra-
tio. Chloroform was evaporated to dryness under a constant flow of N2 gas,
and then under vacuum overnight. LCP samples were prepared at 40% w/w
hydration by mechanical mixing of the appropriate mass of lipid fraction
and buffer solution with or without protein, according to the established
protocol (16), transferred directly into the NMR rotor and then centrifuged
in a desktop centrifuge (~ 5 min at 3354 g). Approximately 30 to 40 mg
of material was used in each NMR experiment, and, where included, pro-
tein concentrations in these samples were 0.60 mM (b2AR) or 1 mM
(KpOmpA). 1H and 13C spectra of samples prepared with and without
this centrifugation step were compared, and there was no evidence that
the LCP was disrupted by centrifugation. Once prepared, samples were
maintained at 20C. All experiments were conducted within 5 days of
sample preparation, and the stability of the samples over this period was
monitored by 1H NMR.
Cholesterol b2AR Interactions 2307LCP-Tm thermostability assay
b2AR-T4L thermostability in LCP was measured following the published
LCP-Tm protocol (14) using intrinsic protein fluorescence as a reporter
for the protein folding state for samples containing timolol and CPM
(7-diethylamino-3-(40-maleimidylphenyl)-4-methylcoumarin, Invitrogen,
Carlsbad, CA) for samples containing carazolol. A full description of the
LCP procedure and of the fitting of the Tm data to obtain an estimate for
n and KD is given in the Supplementary Material.TABLE 1 Average chemical shifts and assignments of sterol
methyl peaks in LCP and chloroform
Sterol Carbon number d (ppm) in LCP d (ppm) in CDCl3
Cholesterol 18 11.84 11.84NMR spectroscopy
All NMR experiments were performed on a BRUKER Avance narrow
bore spectrometer operating at a 1H Larmor frequency of 500.13 MHz
and using Topspin 1.3 software (BRUKER, Billerica, MA). Spectra
were acquired using a 4 mm BRUKER HR-MAS gradient probe with a
deuterium lock, and unless otherwise specified, data was acquired at a
MAS frequency of 5 kHz and a temperature of 20C (calibrated using
ethylene glycol). Direct and INEPT transfer heteronuclear STD pulse se-
quences and phase cycling (for I0–Isat and I0 experiments) were con-
structed according to the published schemes (26), with 2.5 kHz waltz16
power-gated 1H decoupling during acquisition time and a 0.5 s interscan
(d1) delay. The presaturation duration (3.0 s unless otherwise specified)
consisted of a train of Gaussian pulses of length 60 ms with a radio-
frequency field of 300 Hz, separated by 1 ms. The irradiation frequency
of the presaturation pulse in the 1H spectrum was either 8.6 ppm (on pro-
tein amide protons, i.e., on-resonance) or 100.0 ppm (i.e., off-resonance).
The typical duration of a pair of I0–Isat (namely STD experiment) and I0
experiments was 3 days for a single sample containing natural abundance
cholesterol (32k and 16k scans for Isat and I0 experiments, respectively),
or 24 h for a sample containing 13C-labeled cholesterol (8k and 4k
scans for Isat and I0 experiments, respectively). All NMR data analysis
was performed using Topspin (version 2.1 or 3.2) software (BRUKER,
Billerica, MA).
The STD amplification factor (A Factor)—which describes the amount
of magnetization transferred from the saturated protein to the lipid—was
calculated according to the following Eq. 1, as reported by Mayer et al.
(24), where I0 and Isat are the integral of a given resonance for saturation
frequency applied off and on-resonance, respectively, and LE is the molar
ligand excess:
A Factor ¼ I0  Isat
I0
 LE (1)
The A Factor is proportional to the sterol bound fraction (see data analyses
in Supplementary Material). Note that it is not necessarily valid to compare
the A Factor values between different peaks because of differences in relax-
ation times.19 19.31 19.38
21 18.69 18.70
26 and 27 22.41 and 22.61 22.55 and 22.81
Ergosterol 18 11.96 12.01
19 15.88 16.25
21 –a 21.07
26 and 27 19.65 and 19.81 19.61 and 19.91
28 17.69 17.57
All chemical shifts for LCP spectra were recorded in samples containing 2.5
mol% cholesterol and 2.5 mol% ergosterol in monoolein-based LCP at 40%
w/w hydration. Chemical shifts were calibrated to the chemical shift of
cholesterol C18 at 11.84 ppm. The uncertainty on the chemical shifts is
5 0.05 ppm.
aOverlap with cholesterol 11 and ergosterol 21 at ~ 21.15 ppm. Additional
information regarding the chemical shifts of cholesterol in various phases
can be found in (33,34,38).NMR control experiments and sample
characterization
The stability and homogeneity of the LCP at this frequency was determined
by comparing the shape and intensity of the H2O peak in the
1H spectrum
before and after each experiment. At a MAS frequency of 5 kHz, no signif-
icant broadening or diminution of the water peak was observed, indicating
that there was no introduction of inhomogeneity or dehydration of the sam-
ple during the experiments. The 5 kHz frequency was selected as the min-
imum frequency that avoided any overlap of the STD presaturation pulses
with spinning side bands from the MO and cholesterol peaks in the 1H
spectra. As a control, the STD experiments were also performed without
protein to check the selectivity and efficiency of signal subtraction of pre-
saturation off or on-resonance, and corrected when necessary (i.e., for
intense MO peaks) before the A Factor calculation.1D 1H and 13C spectra were acquired for all samples, to confirm that
there were no significant changes (i.e., < 0.001 ppm) in relative chemical
shifts in samples with different cholesterol concentrations or protein com-
positions. Similarly, 13C and 1H line-widths, and 1H T1 relaxation times do
not change significantly for sterol or MO peaks in samples containing 0.5,
1.5, 2.5, 3.5, or 5 mol% cholesterol5 b2AR (data not shown). Therefore,
variations in A Factor could not be interpreted in term of alterations in in-
ternal dynamics of the LCP because of cholesterol content but rather as
direct probe of the interaction between membrane proteins and either
MO or sterols and thus on the contact probability between these molecules.
Partial assignments of 13C chemical shifts for the sterols were carried out
with reference to published data (33–37). The most intense and well-
resolved sterol peaks in the 13C NMR spectra of the various LCP samples
were those of the methyl peaks in the sterol side chains (see Fig. 1 for sterol
structures with carbon numbering). The chemical shifts and assignments of
the sterol methyl peaks in LCPs, and in chloroform solution for comparison,
are given in Table 1. Detailed comparisons of the chemical shifts of choles-
terol in CDCl3 solution, lipid bilayers and in LCP were previously reported
(33,34,38). Although the addition of proteins or peptides to the LCP can
potentially affect diffusion rates of lipids (18) and phase transitions,
b2AR did not significantly alter any of the cholesterol
13C chemical shifts
in our samples, indicating that the protein did not have a particular effect
on the cholesterol-MO-water hydrogen-bonding network at the lipid-water
interface.RESULTS AND DISCUSSION
Specificity of the cholesterol-b2AR interaction
from STD and thermal denaturation data
For the purposes of identifying selectivity in the cholesterol-
b2AR interaction, STD experiments were conducted on
two sets of samples. The first set of samples used
non-13C-labeled sterol, and each sample contained a total
of 5 mol% sterol (2.5 mol% cholesterol and 2.5 mol%
ergosterol). Within this set, three samples were prepared:
a sample without protein (to estimate nonspecific magneti-
zation transfer or background error); a sample containing
KpOmpA (control protein); and a sample containing
b2AR. The following comparisons could then be made: first,Biophysical Journal 107(10) 2305–2312
2308 Gater et al.the difference (if any) between the A Factor for equivalent
carbon positions in the two sterols in any particular sample,
and second the difference (if any) between the A Factor for
the equivalent carbon position of a particular sterol in the
sample containing b2AR and in the sample containing
KpOmpA. The STD spectra (I0 and I0–Isat) for the sample
containing b2AR are shown in Fig. S1 in the Supporting Ma-
terial, and the calculated A Factor values are given in Fig. 2.
Note that the A Factor was only calculated for positions
C26/27 where there was no overlap between two sterol
peaks or between sterol and MO peaks for both the peak
on cholesterol and the equivalent peak on ergosterol, and
where there was sufficient signal-to-noise.
In the case of the samples containing cholesterol and
ergosterol, an increase in the A Factor value for cholesterol
was observed in samples containing b2AR, compared
with the value in samples containing KpOmpA (Fig. 2).
In contrast, no such increases in A Factor values were
observed for the equivalent carbon positions in ergosterol
in samples containing b2AR compared with those contain-
ing KpOmpA. Similarly, the A Factor values for the equiv-
alent carbon positions in cholesterol were larger in samples
containing b2AR than the A Factor values for the same car-
bon positions in ergosterol. These data imply that there is
a selective interaction between cholesterol and the b2AR.
The interaction is protein-specific, because the increase in
A Factor occurs only in the sample containing b2AR and
not in the sample containing KpOmpA. It is also choles-FIGURE 2 Saturation transfer difference A Factors for samples contain-
ing b2AR with natural-abundance
13C cholesterol and ergosterol. The A
Factor values for sterol methyl peaks in samples containing 2.5 mol%
cholesterol and 2.5 mol% ergosterol are plotted. The A Factor reports the
amount of magnetization transferred from the protein to the sterol, and
thus the contact probability between the two species. Samples contained
95 mol% monoolein in the lipid mix and were hydrated with 40% w/w
buffer containing either KpOmpA (dark gray bars) or b2AR (light gray
bars). Experiments were conducted at 25C. Error bars were calculated
with reference to differences between experiments repeated on the same
sample.
Biophysical Journal 107(10) 2305–2312terol-specific, because the increase in A Factor in the
b2AR sample occurs only for cholesterol and not for
ergosterol.
In a second set of experiments we analyzed competition
for binding between cholesterol and ergosterol by varying
the molar concentration of ergosterol in the sample. We
used 25,26,27-13C3-cholesterol (2.5 mol%) in MO for sensi-
tivity reasons, with either 0, 1.5, or 2.5 mol% unlabeled
ergosterol. In agreement with the data obtained using unla-
beled sterols, the presence of 0 mol%, 1.5 mol%, or 2.5 mol
% ergosterol in a sample containing 2.5 mol% cholesterol
with b2AR did not significantly alter the A Factor of the
cholesterol in the presence of b2AR. The fact that ergosterol
does not compete with the cholesterol in binding reveals a
notable structural specificity considering the similarity of
the cholesterol and ergosterol structures (see Fig. 1).
As an additional control, the STD values for the MO
methyl peak were also measured for samples containing 5
mol% cholesterol with either b2AR or KpOmpA. There
was no significant difference between the A Factor for
MO with KpOmpA compared with b2AR, indicating that,
similar to ergosterol, there is no selective interaction be-
tween MO and b2AR (Fig. S2 in the Supporting Material).
It was further observed that the initial build-up rate of
STD was faster for cholesterol than for MO resonances
(Fig S3), again indicating a stronger affinity of the b2AR
for cholesterol.
The selectivity of interaction between b2AR and choles-
terol with respect to other sterols was also observed by
LCP-Tm thermal denaturation data (Fig. 3 A and B):
although cholesterol has a strong, concentration-dependent
effect on the thermal stability of b2AR with saturation
reached at 1 mol%, ergosterol (a yeast sterol) and the struc-
turally related sterols stigmasterol (a plant sterol) and 7-
dehydrocholesterol have no substantial effect on the melting
transition (Tm) of the protein up to 10 mol%.Estimating KD for the cholesterol-b2AR
interaction from STD data and LCP-Tm
A Factors were measured for the cholesterol C26/27 peak at
22.3 ppm based on data from five samples containing b2AR
with cholesterol compositions of 0.5, 1.5, 2.5, 3.5, or 5 mol
% in MO (Fig. 4). Note that a cholesterol concentration of
0.5 mol% corresponds to a ligand excess of ~ 23.5 (235
for 5 mol%), so that over the entire titration range choles-
terol is in large excess with respect to b2AR. The (I0–Isat)
term in the A Factor equation is directly proportional to
the cholesterol bound fraction in the sample. The A Factor
is expected to increase with cholesterol concentration, but
what is significant in Fig. 4 is that it increases linearly
(R2 ¼ 0.966), which implies weak binding (see data Anal-
ysis 1 in the Supporting Material and (24)). By varying
the dissociation constant KD, and plotting the bound fraction
over the same range of cholesterol concentrations, the
A B
FIGURE 3 Effect of sterol concentration on ther-
mal denaturation of b2AR. The thermal denatur-
ation temperature (Tm) of b2AR in LCP samples.
(A) Samples containing cholesterol (diamonds),
ergosterol (squares), stigmasterol (triangles), or
7-dehydrocholesterol (circles), over a 0 to 10 mol
% range, for b2AR bound to carazolol. (B) Expan-
sion of thermal denaturation curves for b2AR
bound to carazolol in the 0 to 1 mol% cholesterol
range, with equilibration time of 2 min (squares),
5 min (diamonds), or 30 min (triangles). A similar
result was obtained for b2AR bound to timolol.
Cholesterol b2AR Interactions 2309minimum value of KD for which a predominantly linear
trend is seen, considering errors, can be estimated as 0.1
M. Fig. S4 shows that for a KD% 0.05 M, a highly nonlinear
dependence of A Factor on cholesterol concentration should
be observed.
The LCP-Tm denaturation data provide a very distinct
picture of the cholesterol effect. A closer look at the 0 to
1 mol% range of concentrations (Figs. 3B and S5) reveals
a sigmoidal curve, which is characteristic of a certain degree
of cooperative binding. The relevant timescale for the dena-
turation experiment is 5 min per temperature point, and
we have shown that the Tm values do not vary with equili-FIGURE 4 A Factors versus cholesterol concentration for samples con-
taining b2AR. Plot of A Factors calculated from STD data versus choles-
terol concentration for samples containing b2AR. Samples were hydrated
with 40% w/w buffer containing b2AR. Experiments were conducted at
20C. Error bars were calculated with reference to differences between ex-
periments repeated on the same sample.bration times between 2 and 30 min (Fig. 3B). In the case of
fast exchange of cholesterol on this timescale, the denatur-
ation of cholesterol-free receptor would drive the whole
population toward denaturation by shifting the binding equi-
librium. In the case of slow exchange, the observed Tm is
proportional to the cholesterol-bound receptor fraction
(see Analysis 2 in the Supporting Material and Fig. S5 for
additional material). The Tm curve can thus be fitted by a
standard Hill binding law (cholesterol in excess, n equiva-
lent binding sites), with n ¼ 3 to 5 (n < 3 and n > 5 clearly
give poor fit to the data points; whereas n ¼ 3 to 5 gives
reasonable fit considering experimental errors), and a KD
in the subnanomolar range.DISCUSSION
Specificity of a GPCR for a particular sterol structure has
been observed previously with the serotonin1A receptor,
whose ligand binding function can be restored by choles-
terol or desmosterol (39), but not by 7-dehydrocholesterol
(40). Similar effects have been observed with the oxytocin
receptor (41,42). In this study, we have revealed two distinct
classes of cholesterol binding sites on b2AR. The high-affin-
ity binding sites observed by LCP-Tm correspond to choles-
terol molecules in slow exchange on the minute timescale.
These could not be observed by STD-NMR, which requires
fast exchange on T1 timescales, (i.e., exchange rates faster
than 1 Hz). What is striking in this situation is that both
of the observed binding affinities are specific for cholesterol,
even that corresponding to a low-affinity–very fast exchange
situation. The specificity was confirmed for the low affinity
both on the part of the protein (KpOmpA versus b2AR) and
on the part of the sterol (cholesterol versus other ergosterol).
One possible explanation for this finding with cholesterol
and b2AR would be that the tightly bound (nonannular)Biophysical Journal 107(10) 2305–2312
FIGURE 5 Binding sites of cholesterol in GPCR x-ray structures. A
representative GPCR structure with a composite map of cholesterol binding
sites, derived from the structures shown in Table 2. Cholesterol (blue car-
bons) and palmitate (yellow carbons) are shown in spheres representation.
Two horizontal lines correspond to membrane boundaries. The extracellular
side (EC) is on top, and the intracellular side (IC) is bottom. Cholesterol
molecules participating in crystal contacts or dimerization interface are
indicated in Table 2. It should be stressed that the LCP-Tm data presented
confirm the presence of three to five high-affinity binding sites but do not
address the issue of their localization on the receptor surface. To see this
figure in color, go online.
2310 Gater et al.cholesterol molecules create an environment suitable for
lower-affinity (annular) binding of sterols (43). This leads
to the idea of a cluster of cholesterol molecules around
the b2AR, certain molecules being in slow exchange and
others in fast exchange, with the former contributing to
the specific binding of the latter. This may have implications
on the effects of cholesterol on the oligomerisation state of
b2AR (44) and on the recruitment of b2AR in cholesterol-
rich domains (45). Although this concept is still speculative
at this stage, we dare to propose it as it provides a framework
for devising future experiments.
The potential existence of three to five high-affinity choles-
terol binding sites is supported by x-ray structures of the
b2AR (5,6). Overall at least seven distinct cholesterol binding
sites have been observed in crystal structures of seven
differentGPCRs (Fig. 5 andTable 2) and recentmolecular dy-
namics simulations revealed seven potential cholesterol bind-
ing sites on the surface of b2AR (46). All these results agree
well with our estimation of the number of up to three to five
high-affinity cholesterol binding sites based on LCP-Tm
data. Physiologically, the disruption of native cellmembranes
by cholesterol-depleting agents such as methyl-b-cyclodex-
trin (MbCD) results in an increase in b2AR signaling (47)
but has no apparent effect on protein clustering (48), which
ismore sensitive to the actin cytoskeleton.However, the effect
of cholesterol depletion on signaling of the nonraft-associated
b2AR in vitro has been linked to the release of theGas andAC
proteins from sequestration in lipid rafts, rather than on a
direct interaction between b2AR and cholesterol (49), and
thus additional work is required to link the data presented
here with the in vitro studies to more fully elucidate the role
of cholesterol in b2AR function.
Although the physiological consequences of b2AR-
cholesterol interactions remain to be further clarified, there
is considerable evidence for both specific and nonspecific
effects of cholesterol on the function of various other
GPCRs. For example, in the case of rhodopsin (recently re-
viewed in (50)), the thermal stability of rhodopsin isTABLE 2 Summary of reported cholesterol-GPCR binding sites sh
Site no. GPCR PDB ID No. of cholesterol Bind
1 b2AR 2RH1, 3D4S 2 IC;
b1AR 2Y00 1 (CHS) IC; heli
P2Y12 4PXZ 1 IC; heli
2 b2AR 2RH1 1 IC; helice
5HT2B 4IB4 1 IC; helice
3 b1AR 2Y00 1 (CHS) IC; h
P2Y12 4NTJ 1 IC;
4 A2AAR 4EIY 1 EC;
b1AR 2Y00 1 (CHS) E
5 A2AARm-OR 4EIY4DKL 11 EC; helices VI–VII
6 P2Y12 4NTJ 1 EC;
7 A2AAR 4EIY 1 EC; heli
mGlu1 4OR2 3 EC; N-term
Biophysical Journal 107(10) 2305–2312increased by the addition of cholesterol in both egg-phos-
phatidylcholine bilayers (51) and in intact disk membranes
(1). High cholesterol contents also reduce rhodopsin
signaling via cGMP by altering the meta I/meta II (MI/
MII) conformational equilibrium, with increasing choles-
terol concentrations favoring the signaling-inactive MI state
(1,52,53). These effects have been suggested (50) to result
primarily from the effect of cholesterol on the fluid proper-
ties of the bilayer, including curvature forces (54,55), rather
than from a specific interaction between cholesterol and
the protein, although indications of direct interaction haveown in Fig. 5
ing interface Crystal contacts (C) or dimer interface (D)
helices I–IV C
ces II–IV, ICL1
ces II–IV, ICL1
s I, VIII, palmitate D
s I, VIII, palmitate
elices III–V C
helices III,V C
helices V–VI C
C; helix V C
, ECL3EC; helices VI–VII,
ECL3
helices VII, I
ces II–III, ECL1 C
, helices I–III, ECL1 D
Cholesterol b2AR Interactions 2311also been described in the literature (1,56). Conversely, in
the case of the oxytocin receptor, cholesterol affects the
ligand binding affinity (57,58) and downstream signaling
(59), and increases protein thermal and pH stability (41).
Cholesterol also induces a more compact conformational
state of the oxytocin receptor (60). Hill analysis of oxytocin
binding versus cholesterol content suggest that at least six
cholesterol molecules bind to oxytocin receptor in a cooper-
ative manner (61). The effect of cholesterol on the oxytocin
receptor has been proposed to result from a specific interac-
tion, rather than from a general effect of cholesterol on the
bulk physical properties of the membrane (57), and muta-
genesis studies have identified regions of the oxytocin
receptor sequence that are important for cholesterol sensi-
tivity (62). Many other GPCRs also exhibit sensitivity to
cholesterol, although the mechanisms for these responses
are generally not yet well understood.SUPPORTING MATERIAL
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